Researcher
Benoit Beuselinck
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Feb 2011 → Today
Projects
1 - 6 of 6
- Response prediction in metastatic clear-cell renal cell carcinoma treated with angiogenesis and/or immune checkpoint inhibitorsFrom1 Oct 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Medication-related osteonecrosis of the jaw (MRONJ) - Balancing treatments benefits and risksFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom5 Dec 2019 → 30 Sep 2021Funding: BOF - projects
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORTARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom1 Oct 2019 → TodayFunding: FWO fellowships
- Patient selection strategies throughout the renal cell carcinoma disease spectrumFrom1 Aug 2019 → 6 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
41 - 50 of 152
- Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival(2021)
Authors: Benoit Beuselinck
- C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab(2021)
Authors: Eduard Roussel, Lisa Kinget, Marcella Baldewijns, Hendrik Van Poppel, Maarten Albersen, Benoit Beuselinck
- Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort(2021)
Authors: Hans Wildiers, Kevin Punie, Benoit Beuselinck, Paul Clement, Sileny Han, Els Van Nieuwenhuysen, Ignace Vergote, Ann Smeets, Ines Nevelsteen, Beppe Floris, et al.
Pages: 1041 - 1048 - Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".(2021)
Authors: Patrick Schöffski, Daphne Hompes, Veerle Boecxstaens, Paul De Leyn, Willy Coosemans, Dirk Van Raemdonck, Esther Hauben, Raf Sciot, Paul Clement, Oliver Bechter, et al.
Pages: 4653987 - NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab(2021)
Authors: Benoit Beuselinck
Pages: S704 - S705 - The role of radiation therapy and particle therapy in renal cell carcinoma: current evidence and future perspectives(2021)
Authors: Charlien Berghen, Maarten Albersen, Kato Rans, Benoit Beuselinck, Steven Joniau, Karin Haustermans, Gert De Meerleer
- Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration(2021)
Authors: Eduard Roussel, Loic Baekelandt, Benoit Beuselinck, Maarten Albersen
Pages: 133 - 140 - Long-Term Outcomes in Clear-Cell Renal Cell Carcinoma Patients Treated with Complete Metastasectomy(2020)
Authors: Eduard Roussel, Steven Joniau, Annouschka Laenen, Paul Clement, Agnieszka Wozniak, Maarten Albersen, Benoit Beuselinck
Pages: 177 - 183 - Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy(2020)
Authors: Murat Akand, Annelies Verbiest, Benoit Beuselinck, Maarten Albersen, Eduard Roussel, Hendrik Van Poppel, Steven Joniau
- Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma(2020)
Authors: Eduard Roussel, Annelies Verbiest, Ben Van Cleynenbreugel, Hendrik Van Poppel, Steven Joniau, Benoit Beuselinck, Maarten Albersen
Pages: 493 - 499